Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public HealthAbortion Drugs Journal of American Physicians and Surgeons

Chemical Abortion: Risks Posed by Changes in Supervision

Abstract

The FDA has approved a chemical abortion regimen of mifepristone and misoprostol since 2000, though recent years have noted progressive loosening of restrictions.  Although U.S. chemical abortion complication data is difficult to obtain due to voluntary reporting and other known deficiencies in data collection, better quality international data indicates that complications occur relatively frequently, with 3-8% of women requiring surgical completion.  Recent FDA actions removing in-person supervision are likely to increase complications further, due to underestimation of gestational age, missed diagnoses of ectopic pregnancy, failure to test for Rh D factor and provide RhoGAM if indicated, increased potential for coercion, as well as other factors.

Read Complete Article

Latest Posts

July 20, 2026 A woman in a hospital gown is in labor, holding someone's hand for support while medical staff assist during childbirth, closely monitoring for any medical indications that might require separating mother and unborn child. Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child July 20, 2026 Abortion Reporting: Wyoming (2025) July 20, 2026 Abortion Reporting: South Dakota (2025)

You Might Also Be Interested In

A woman in a hospital gown is in labor, holding someone's hand for support while medical staff assist during childbirth, closely monitoring for any medical indications that might require separating mother and unborn child.

Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child

July 20, 2026
Please login to bookmark Close

Abortion Reporting: Wyoming (2025)

July 20, 2026
Please login to bookmark Close

Abortion Reporting: South Dakota (2025)

July 20, 2026
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image